▲ The AccE Glass-Free Detector offers a more comfortable imaging experience due to its lightweight design, which lessens user fatigue without compromising image quality.

To optimize work efficiency and portability, Samsung has introduced a new flagship detector, the AccE Glass-Free Detector. The AccE Glass-Free Detector recently received 510(k) clearance from the U.S. Food and Drug Administration for commercial use in the USA.

“Being at the forefront of advancing healthcare imaging, we have recognized the need for new solutions that enhance both patient and user comfortability,” said David Legg, Vice President, Head of Boston Imaging. “From the ER to the OR, our Glass-Free Detector exhibits reliability in versatile environments to help get the job done — and done well.”

The AccE Glass-Free Detector was designed to deliver high-resolution images of a digital detector, while offering exceptional user and patient benefits, including:

The AccE Glass-Free Detector was designed to deliver high-resolution images of a digital detector, while offering exceptional user and patient benefits, including:

• Lightweight Design: Weighs approximately 4.5 pounds,¹ which is 27 percent lighter than the conventional model.²
• Clear Visibility: Exhibits a 76% DQE, leading the market in glassless panel technology.
• Functionality: Features a non-glass flexible panel with center-engraving to position a patient, a side chamfer to ease lifting and a rear grip to support transportation.
• High Load Allowance: Holds up to 881 pounds of surface load and 441 pounds of patient load.³
• Dust and Water Resistant: Enables users to employ the detector with confidence in fast-paced environments.

Samsung persistently works to help professionals by developing best-in-class imaging technology that optimizes functionality. The AccE Glass-Free Detector can be used on the AccE GM85 mobile Digital Radiography system and is coming soon to the AccE GC85A.

To learn more about the AccE Glass-Free Detector, please visit here.

About Boston Imaging

Boston Imaging markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Boston Imaging is the United States headquarters for sales, marketing, clinical, service and commercialization of all Samsung digital radiography and ultrasound systems. Boston Imaging’s growing portfolio of advanced medical technologies is used in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction and increase workflow efficiency. For more information, please visit https://www.bostonimaging.com/.

¹ Measured without battery set

² Compared to S4335-AW

³ Based on 40 mm diameter disc at the center

Boston Imaging, the United States headquarters of Samsung digital radiography and ultrasound systems, introduces the GM85 Fit, a new configuration of the premium AccE GM85; a digital radiography device featuring a user-centric design that aids in efficient and effective patient care. The GM85 Fit recently received 510(k) clearance from the U.S. Food and Drug Administration for commercial use in the USA.

“We are pleased to launch the GM85. It’s designed with the user in mind, from its lightweight design to its array of features,” said David Legg, Vice President, Head of Boston Imaging. “This solution is the latest addition to our best-in-class family of products. As the procedure volume of mobile X-ray increases to deal with unprecedented patient volume, Samsung continues to focus on creating more efficient mobile imaging solutions.”

Powered by a lead-free lithium-ion battery, the GM85 Fit provides users with a more value-oriented mobile X-ray device that has high efficiency, throughput and workflow features and a long lifespan. Specifically, the GM85 Fit features:

• Rapid Charging: Charges within three to four hours.¹
• Exceptional Operational Capabilities: Can take up to 550 exposures and drive up to 37.3 miles during 11 hours of use without additional charging.²
• Enhanced Performance: Can take up to 1,900 exposures or be on standby for up to 35 hours on sleep mode.^3,4
• User-Centric Design: The ultralight design of the GM85 Fit delivers an effortless driving experience. The detector is also lightweight, which supports easier patient positioning for the technologist.
• Quiet Operation: Operates at low noise levels, less than 42 dB, during standby and Night Mode for quick control of device sound and brightness to avoid disturbing patients.

In addition to refining usability, Samsung continuously seeks new ways to help clinicians find reliable answers with greater image clarity and enhanced diagnostic accuracy. The GM85 Fit features an upgraded version of Samsung’s S-Vue imaging processing engine, which mitigates halo artifacts surrounding metallic objects to allow for proper visualization of the bone-metal interface, all while reducing dose levels by up to 47.5 percent for adult abdomen imaging and 45 percent for pediatric abdomen imaging.⁵ The device also features the MirrorView function that allows secured screen sharing for healthcare professionals to review images.

The GM85 Fit also features key tools that are found within the premium AccE GM85, such as:

• Auto Lung Nodule Detection: A computer-aided detection software designed to identify and mark regions in relation to suspected pulmonary nodules from 10 to 30mm in size.
• S-Enhance: Improves clarity of foreign bodies in images of chest abdomen and L-spine.
• SimGrid: Improves image quality of non-grid images to a level comparable to grid images while at the same time reducing radiation dose, especially beneficial for obese patients.
• Bone Suppression: Improves the clarity of soft tissues by suppressing the appearance of bones in chest images.

To learn more about the GM85 Fit, please visit https://www.samsunghealthcare.com.

About Boston Imaging

Boston Imaging markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Boston Imaging is the United States headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Boston Imaging’s growing portfolio of advanced medical technologies is used in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction and increase workflow efficiency. For more information, please visit https://www.bostonimaging.com/.

¹ 200 ~ 240 VAC < 3 hours, 100 ~ 127 VAC < 4 hours

² Test condition : Chest AP / 80 kVp / 160 mA / 5 msec / 60 sec intervals, moving in maximum velocity (5.6 km/h)

³ Test condition : Chest AP / 80 kVp / 160 mA / 5 msec / 20 sec intervals, without moving

⁴ Stand-by 19 hours for LCD on, 35 hours for sleep mode and 75 hours for power off

⁵ Note: The claim concerning Samsung DR is based on limited phantom and clinical study results. Only routine PA chest radiography and abdominal radiography for average adults and pediatric abdominal, chest, skull radiography were studied, excluding pediatric patients under 1 month old. (FDA cleared – K172229, K182183) In practice, the values of dose reduction may vary accordingly. These clinical images calculate the dose reduction rate from its own standard dose at the clinical site, unlike our FDA claim which com­pares dose between new IPE and old IPE. The clinical site is responsible for determining whether the particular radiographic imaging needs are not impacted by such x-ray dose reduction.

“This has been a momentous year for Samsung. We have worked to advance our solutions by leveraging high computing power and artificial intelligence (AI) technologies,” said David Legg, Vice President, Digital Radiography and Ultrasound, NeuroLogica. “We will be deploying AI features in each of our products to provide benefits to healthcare professionals and patients alike.”

Ultrasound

At the event, Samsung will showcase its new V8, which is a premium ultrasound system that provides enhanced image quality, usability and convenience for ultrasound professionals. Crystal Architecture is the core of the V8’s image clarity and penetration and is built upon the combination of innovative beamforming (CrystalBeam), sophisticated image processing (CrystalLive) and advanced S-Vue Single Crystal Transducers to produce clear, uniform and high-resolution images.

The feature-packed device includes two new AI functions, one being NerveTrack, which detects nerves and provides nerve location information in real-time to anesthesiologists and expert practitioners. The function is designed to provide users with accurate nerve detection, faster image processing and better workflow support. The second AI function is UterineAssist, which detects tissue changes and assists the user in taking measurements of the uterus. With these and other new tools, the V8 delivers a new level of versatility and value to a wide range of diagnostic medical ultrasound departments.

Samsung has also worked to advance its ultrasound solutions for women’s health. Recently, the Hera W9 and W10 received Food and Drug Administration (FDA) 510(K) clearance for its new AI functions, which gives the operator the ability to measure anatomical structures and analyze imaging, providing useful information to aid diagnosis.

New features include:

• HeartAssist: A deep learning-based function that provides classification of ultrasound images to display measurements. The feature recognizes various views and proposes caliper placements and corresponding measurements allowing users to save time with measurement proposals and increase examination efficiency by reducing keystrokes.
• ViewAssist: A deep learning-based function that classifies ultrasound images to deliver key scanning views and provides annotations. The feature recognizes a range of views, proposes corresponding anatomy annotations and initiates measurements.
• BiometryAssist: An automatic solution for biometric measurement that can be modified by the user. It enables users to measure fetal growth parameters with one click while maintaining exam consistency.

Digital Radiography

Samsung is also showcasing its premium digital mobile X-ray, the AccE GM85, which delivers unparalleled performance and gives users better diagnostic confidence while improving workflow. Recently, Samsung received FDA 510(k) clearance for its Auto Lung Nodule Detection (ALND) tool, which can be utilized in the AccE GC85A and in other systems. The ALND is provided as an on-device computer-assisted detection (CADe) software that uses an AI algorithm to detect pulmonary nodules between 10 and 30mm in size.¹

The benefits of ALND include:

• Aids the user in the diagnostic process by indicating the location of suspected lung nodules on chest X-ray images (posteroanterior chest radiographs).
• Offers the option (Autorun) to automatically perform nodule detection immediately after chest X-ray imaging in addition to PACS transmission options to suit the hospital environment, both of which simplify the user’s workflow.
• The ALND has been clinically verified by multiple university hospitals and has been approved with a sensitivity of 80% or more.² As part of Samsung’s commitment to advancing diagnostic radiology using AI, Samsung will expand the uses of the chest CADe solution and continue improving diagnostic accuracy and workflow.

Computed Tomography

Also featured at RSNA is the OmniTom^® Elite – a mobile computed tomography (CT) scanner that delivers high-quality non-contrast CT, CT angiography and CT perfusion scans at point-of-care. The OmniTom Elite CT boasts a small footprint and high-resolution image quality. The advancements of the scanner help to optimize diagnostic confidence, speed and workflow across departments, such as neurosurgery, pediatric imaging, critical care, diagnostic radiology and more.

Earlier this year, NeuroLogica announced that the OmniTom Elite with Photon Counting Detector (PCD) technology will be piloted by Massachusetts General Hospital, bringing CT imaging to the patient’s point-of-care. Pending FDA 510(k) clearance, the hospital is testing the OmniTom Elite with PCD to monitor post-trauma and post-surgical patients.

The OmniTom Elite’s ability to provide versatile, real-time mobile imaging enables healthcare providers to administer point-of-care CT to critical patients without the need to transport them to a separate department. The mobile unit will decrease the time it takes to diagnose and initiate treatment for patients in the ICU. During the pilot stage for the OmniTom Elite with PCD, Massachusetts General Hospital will guide best practices and evaluate use cases for the novel system.

Visit Samsung at Booth #6952.

Samsung will showcase its premium diagnostic imaging solutions in ultrasound, digital radiography and mobile computed tomography at the Radiological Society of North America (RSNA) 2021 Annual Meeting.

About Samsung Medison Co., Ltd.

Samsung Medison is a global leading medical device company, founded in 1985. With a mission to bring health and well-being of people’s lives, the company manufactures diagnostic ultrasound systems around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

About NeuroLogica Corp.

NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of mobile computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies is used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. For more information, please visit http://www.NeuroLogica.com.

* Content has been updated as of February 10, 2023 to more accurately reflect product information.

¹ ALND cannot be used on patients who have lung lesions other than abnormal nodules.

² Y. Sim et al, Deep Convolutional Neural Network-based Software Improves Radiologist Detection of Malignant Lung Nodules on Chest Radiographs. Radiology, 2020

At booth #506 (Expo. X5), Samsung is displaying medical equipment based on its ‘AccE’ (Access, Accuracy and Efficiency) strategy, which aims to change the industry by incorporating innovations in physical access to provide care wherever needed. Samsung also seeks to improve accuracy in diagnosis with advanced algorithms and efficiency with advanced display, UX and information management technology developed by Samsung Electronics.

“Samsung is committed to medical advancements for both diagnostic solutions and patient care. We will continue to develop optimized medical equipment to healthcare providers by combining our key values in the pursuit of Access, Accuracy and Efficiency,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison.

Within ultrasound systems, Samsung has made great achievements in Obstetrics and Gynecology and will continue to expand its portfolio to the radiology segment. At ECR 2018, Samsung will present upgraded ultrasound systems including:

• RS85, Samsung’s advanced premium ultrasound system for radiology that provides enhanced image quality and convenience for medical and radiology professionals. The RS85 features MV-Flow technology, which detects blood flow in the microvascular, and S-Shearwave Imaging, which provides new indicators for clinical diagnosis by quantifying the elasticity of tissue. The S-Fusion function extends analysis from the abdomen to the prostate, and also allows coordination and simultaneous comparative analysis of images from other modalities such as MRI and CT for easy and fast biopsy.

• HS70A with Prime, the high-end ultrasound system specifically designed to fit into a general ultrasound imaging setting from routine to complex. It features Arterial Analysis, which detects changes in vessels, providing measurement values such as stiffness. The S-Shearwave and Realistic Vue are additional features that improve image quality.

Samsung will also introduce digital radiography solutions that manage the dose for patients and meet the needs of healthcare providers, including:

• GC85A, which provides outstanding images that boost diagnostic confidence equipped with technologies such as S-Detector and S-Align. The device adopts Low Dose technology for enhanced patient safety. Samsung recently cleared in the U.S. FDA for 50% dose reduction in adults’ chest exams, using GC85A with the new imaging engine S-Vue3.02.

• GM85, a lighter version of original GM85 will be displayed. The weight is reduced, but the functional benefits such as enhanced mobility and streamlined workflow are still retained. GM85 provides advanced patient care through leading edge imaging functions.

At the Beyond Experience Zone, visitors can learn about Samsung’s efforts in supporting radiologists in their diagnoses through various software technologies such as SimGrid^TM, Bone Suppression and Dose Reduction. In addition to superb medical equipment, healthcare providers can visit the Low Dose Campaign Zone and experience how low the radiation dose of GC85A is compared to real life radiation through the Low Dose Quiz.

Samsung Electronics’ subsidiary NeuroLogica will showcase innovative mobile CT OmniTom^®, which features an array of improvements from Samsung’s award-winning CereTom^® CT scanner. OmniTom^® is ideal for cranial procedures and is designed to deliver high-quality non-contrast CT, CT angiography and CT perfusion scans. The combination of its rapid scan time, ultra-small footprint and immediate image viewing makes OmniTom^® an indispensable tool for collecting real-time data on critically ill patients. Samsung will also show its spectral CT with Photon Counting Detector (PCD), the next generation of CT technology.

Samsung is also presenting a prototype of Extremity MRI, which is expected to be a game changer in the industry. It is designed to improve not only cost and space efficiency but also patient convenience, as it reduces the need for the whole body to be in the MRI device to scan extremity areas such as arms and legs.

In addition to showcasing its portfolio of comprehensive healthcare solutions, Samsung will be hosting two satellite symposia throughout the week at ECR. Samsung’s symposia will highlight the key trends and issues across ultrasound imaging and digital radiography technologies.

For more information on Samsung’s healthcare division, its subsidiaries and products, please visit https://www.samsunghealthcare.com/.